E-LIB Suche - Ergebnisse für: Heist, Rebecca S

1

Clinical management, monitoring, and prophylaxis of adverse..:

Heist, Rebecca S. ; Sands, Jacob ; Bardia, Aditya...
Cancer Treatment Reviews. 125 (2024) - p. 102720 , 2024

Link: https://doi.org/10.1016/..

2

Phase I/II Study of Combined BCL-xL and MEK Inhibition with..:

Corcoran, Ryan B. ; Do, Khanh T. ; Kim, Jeong E....
Clinical Cancer Research. 30 (2024) 9 - p. 1739-1749 , 2024

Link: https://doi.org/10.1158/..

3

Activating Point Mutations in the MET Kinase Domain Represe..:

Pecci, Federica ; Nakazawa, Seshiru ; Ricciuti, Biagio...
Cancer Discovery. , 2024

Link: https://doi.org/10.1158/..

4

Efficacy and Tolerability of ALK/MET Combinations in Patien..:

Dagogo-Jack, Ibiayi ; Kiedrowski, Lesli A. ; Heist, Rebecca S....
JTO Clinical and Research Reports. 4 (2023) 8 - p. 100534 , 2023

Link: https://doi.org/10.1016/..

5

Patient-reported outcomes in capmatinib-treated patients wi..:

Wolf, Jürgen ; Garon, Edward B. ; Groen, Harry J.M....
European Journal of Cancer. 183 (2023) - p. 98-108 , 2023

Link: https://doi.org/10.1016/..

6

Pembrolizumab in brain metastases of diverse histologies: p..:

Brastianos, Priscilla K. ; Kim, Albert E. ; Giobbie-Hurder, Anita...
Nature Medicine. , 2023

Link: https://doi.org/10.1038/..

7

ANtiangiogenic Second-line Lung cancer Meta-Analysis on ind..:

Remon, Jordi ; Lacas, Benjamin ; Herbst, Roy...
European Journal of Cancer. 166 (2022) - p. 112-125 , 2022

Link: https://doi.org/10.1016/..

8

Brief Report: Safety and Antitumor Activity of Alectinib Pl..:

Kim, Dong-Wan ; Gadgeel, Shirish ; Gettinger, Scott N....
JTO Clinical and Research Reports. 3 (2022) 8 - p. 100367 , 2022

Link: https://doi.org/10.1016/..

9

Implementation and Clinical Adoption of Precision Oncology ..:

Dias-Santagata, Dora ; Heist, Rebecca S ; Bard, Adam Z...
The Oncologist. 27 (2022) 11 - p. 930-939 , 2022

Link: https://doi.org/10.1093/..

10

High-Dose Osimertinib for CNS Progression in EGFR+ NSCLC: A..:

Piper-Vallillo, A.J. ; Rotow, Julia K. ; Aredo, Jacqueline V....
JTO Clinical and Research Reports. 3 (2022) 6 - p. 100328 , 2022

Link: https://doi.org/10.1016/..

11

Activity of Adagrasib (MRTX849) in Brain Metastases: Precli..:

Sabari, Joshua K. ; Velcheti, Vamsidhar ; Shimizu, Kazuhide...
Clinical Cancer Research. 28 (2022) 15 - p. 3318-3328 , 2022

Link: https://doi.org/10.1158/..

12

Phase II Study of Cabozantinib in Patients With Bone Metast..:

Choy, Edwin ; Cote, Gregory M ; Michaelson, M Dror...
The Oncologist. 27 (2022) 7 - p. 600-606 , 2022

Link: https://doi.org/10.1093/..

13

A Phase 2 Study of Lorlatinib in Patients With ROS1-Rearran..:

Schneider, Jaime L. ; Muzikansky, Alona ; Lin, Jessica J....
JTO Clinical and Research Reports. 3 (2022) 7 - p. 100347 , 2022

Link: https://doi.org/10.1016/..

14

Clinicopathologic Characteristics and Outcomes for Patients..:

Cooper, Alissa J. ; Muzikansky, Alona ; Lennerz, Jochen...
JTO Clinical and Research Reports. 3 (2022) 9 - p. 100390 , 2022

Link: https://doi.org/10.1016/..

15

Clinical and Imaging Features of Non-Small Cell Lung Cancer..:

Wu, Markus Y. ; Zhang, Eric W. ; Strickland, Matthew R....
Cancers. 13 (2021) 14 - p. 3572 , 2021

Link: https://doi.org/10.3390/..